Literature DB >> 25997616

Let-7i inhibits the malignant phenotype of osteosarcoma cells by targeting Aurora-B.

Guo Mei Zhang1, Xin Hua Long2, Jia Ming Liu2, Liang Bo Zhu2, Xuan Yin Chen2, Shan Hu Huang2, Zhi Hong Zhang2, Zhi Li Liu2.   

Abstract

Our previous study indicated that Aurora-B is involved in osteosarcoma (OS) cell invasion and metastasis; however, the mechanism underlying Aurora-B overexpression in OS remains unknown. In the present study, significantly downregulated let-7i expression in OS tissues and OS cells was observed compared with that in normal adjacent tumorous tissues and human osteoblast cell lines. Bioinformatic predictions have revealed a conserved binding site in a microRNA locus on Aurora‑B, suggesting the potential of let‑7i targeting the Aurora‑B gene. To validate this, a luciferase reporter assay was performed on OS cells. The results indicated that Aurora‑B is a likely to be a direct target negatively regulated by let‑7i. The expression of let‑7i in OS cells was restored by infection with let‑7i mimics. Results revealed that Aurora‑B mRNA and protein expression levels were significantly decreased. Furthermore, the proliferation, migration and invasion abilities of OS cells were significantly suppressed by infection with let‑7i mimics. Notably, the inhibitory effect of silencing Aurora‑B by LV‑shAurora‑B on cell proliferation, migratory and invasive ability was significantly lower than that by let‑7i mimics, which indicated that let‑7i inhibits cell malignant phenotypes partially by targeting Aurora‑B in OS cells. All data suggested that let‑7i may be a novel potential target for OS treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25997616     DOI: 10.3892/mmr.2015.3798

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  5 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

2.  A regulatory BMI1/let-7i/ERK3 pathway controls the motility of head and neck cancer cells.

Authors:  Lobna Elkhadragy; Minyi Chen; Kennon Miller; Muh-Hwa Yang; Weiwen Long
Journal:  Mol Oncol       Date:  2017-01-12       Impact factor: 6.603

3.  Qingjie Fuzheng Granule Inhibited the Migration and Invasion of Colorectal Cancer Cells by Regulating the lncRNA ANRIL/let-7a/TGF-β1/Smad Axis.

Authors:  Ling Zhang; Jianxin Liu; Shan Lin; Jingzhuang Tan; Bin Huang; Jiumao Lin
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-29       Impact factor: 2.629

4.  Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma.

Authors:  Tianhao Sun; Xing Zhong; Honghai Song; Jiaming Liu; Jingao Li; Frankie Leung; William W Lu; Zhi-Li Liu
Journal:  Cell Death Dis       Date:  2019-04-01       Impact factor: 8.469

5.  FGF-induced LHX9 regulates the progression and metastasis of osteosarcoma via FRS2/TGF-β/β-catenin pathway.

Authors:  Shuang-Qing Li; Chao Tu; Lu Wan; Rui-Qi Chen; Zhi-Xi Duan; Xiao-Lei Ren; Zhi-Hong Li
Journal:  Cell Div       Date:  2019-11-25       Impact factor: 5.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.